Rocuronium Bromide Solution
Product Images NDC 39822-4200

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 39822-4200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xgen Pharmaceuticals Djb, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Rocuronium Bromide Injection 1)

A data table showing infusion delivery rates of rocuronium bromide solution based on patient weight (in kg and lbs) and drug delivery rate (mg/kg/min). It lists infusion delivery rates (mL/hr) for weights from 10 to 100 kg and drug rates from 4 to 16 mg/kg/min.*

FDA Label Image

Rocuronium Bromide Injection 10

Label for Rocuronium Bromide Injection 10 mg/mL solution in a 10 mL multiple dose vial. The label includes a warning that the drug is a paralyzing agent for IV use only. It is manufactured by XGen Pharmaceuticals DJB, Inc., Big Flats, NY 14814, and the product NDC is 39822-4200.*

FDA Label Image

Rocuronium Bromide Injection 11

Packaging label for Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL) solution for intravenous use. The label indicates it contains 10 vials of 5 mL multiple-dose vials. The labeler is XGen Pharmaceuticals DJB, Inc. It includes a warning that it is a paralizing agent and that the container closure is not made with natural rubber latex.*

FDA Label Image

Rocuronium Bromide Injection 12

Packaging label for Rocuronium Bromide Injection, 10 mg/mL (100 mg/10 mL) solution for intravenous use. The label indicates it is a paralyzing agent and is for intravenous use only. The product is supplied in multipledose vials, 10 x 10 mL, manufactured by XGen Pharmaceuticals DJB, Inc.*

FDA Label Image

Figure 1 (Rocuronium Bromide Injection 2)

A data table showing infusion delivery rates in milliliters per hour (mL/hr) based on patient weight in kilograms and pounds, combined with drug delivery rates in micrograms per kilogram per minute (mcg/kg/min). The table helps determine infusion rates for a range of patient weights from 10 kg (22 lbs) to 100 kg (220 lbs) at varying drug delivery rates from 4 to 16 mcg/kg/min.*

FDA Label Image

Figure 2 (Rocuronium Bromide Injection 3)

A data table showing infusion delivery rates (mL/hr) corresponding to drug delivery rates (mcg/kg/min) for different patient weights in kilograms and pounds. The table provides infusion rates for weights ranging from 10 kg to 100 kg and delivery rates from 4 to 16 mcg/kg/min.*

FDA Label Image

Figure 3 (Rocuronium Bromide Injection 4)

Chemical structure of rocuronium bromide, a steroidal neuromuscular blocking agent, showing its molecular arrangement including a bromide ion (Br-). The diagram depicts its ring system and key functional groups, consistent with the active ingredient rocuronium bromide.*

FDA Label Image

5 mL Vial Label (Rocuronium Bromide Injection 5)

A scatter plot showing data points of minutes measured against dosage in mg/kg for different age groups: 18-64 years, over 65 years, and 1-12 years. The x-axis lists dosages with respective age groups, and the y-axis represents time in minutes. Data points vary by dose and age, illustrating variability in time measurements across groups.*

FDA Label Image

10 mL Vial Label (Rocuronium Bromide Injection 6)

A scatter plot chart depicting duration in minutes on the vertical axis against different age groups and dosages of rocuronium bromide in mg/kg on the horizontal axis. The chart compares values for age groups 18-64 years, 65 years and older, 3 months to 1 year, and 1 to 12 years with varying dosages, illustrating variability in duration across these groups.*

FDA Label Image

Rocuronium Bromide Injection 7

A line graph showing the relationship between dose number and time in minutes for two doses of rocuronium bromide, 0.1 mg/kg and 0.15 mg/kg. The x-axis represents dose number from 1 to 6, and the y-axis represents minutes from 0 to 30. Data points show increasing time with dose number for both dosages, with sample sizes of N=29 for 0.1 mg/kg and N=13 for 0.15 mg/kg.*

FDA Label Image

Rocuronium Bromide Injection 8

FDA Label Image

Rocuronium Bromide Injection 9

Label for Rocuronium Bromide Injection 50 mg/5 mL (10 mg/mL) solution for intravenous use. Manufactured by XGen Pharmaceuticals DJB, Inc., Big Flats, NY. The label includes warnings such as 'Paralyzing Agent' and storage instructions, with an NDC number 39822-4200-1, lot, and expiration date sections for product identification.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.